First Time Loading...
M

Magforce AG
XETRA:MF6

Watchlist Manager
Magforce AG
XETRA:MF6
Watchlist
Price: 0.081 EUR -30.47% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

MF6 price has not been updated for more than 5 months. This may indicate that the stock has been delisted.
MF6 doesn't have a meaningful market cap.

MagForce AG engages in the development and distribution of a nanotechnology based cancer therapy. [ Read More ]

There is not enough data to reliably calculate the intrinsic value of MF6.

Key Points:
MF6 Intrinsic Value
Base Case
Not Available
M
Base Case Scenario

Fundamental Analysis

Beta
Ask me anything about
Magforce AG

Provide an overview of the primary business activities
of Magforce AG.

What unique competitive advantages
does Magforce AG hold over its rivals?

What risks and challenges
does Magforce AG face in the near future?

Show all valuation multiples
for Magforce AG.

Provide P/S
for Magforce AG.

Provide P/E
for Magforce AG.

Provide P/OCF
for Magforce AG.

Provide P/FCFE
for Magforce AG.

Provide P/B
for Magforce AG.

Provide EV/S
for Magforce AG.

Provide EV/GP
for Magforce AG.

Provide EV/EBITDA
for Magforce AG.

Provide EV/EBIT
for Magforce AG.

Provide EV/OCF
for Magforce AG.

Provide EV/FCFF
for Magforce AG.

Provide EV/IC
for Magforce AG.

Show me price targets
for Magforce AG made by professional analysts.

What are the Revenue projections
for Magforce AG?

How accurate were the past Revenue estimates
for Magforce AG?

What are the Net Income projections
for Magforce AG?

How accurate were the past Net Income estimates
for Magforce AG?

What are the EPS projections
for Magforce AG?

How accurate were the past EPS estimates
for Magforce AG?

What are the EBIT projections
for Magforce AG?

How accurate were the past EBIT estimates
for Magforce AG?

Compare the revenue forecasts
for Magforce AG with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Magforce AG and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Magforce AG against its competitors.

Analyze the profit margins
(gross, operating, and net) of Magforce AG compared to its peers.

Compare the P/E ratios
of Magforce AG against its peers.

Discuss the investment returns and shareholder value creation
comparing Magforce AG with its peers.

Analyze the financial leverage
of Magforce AG compared to its main competitors.

Show all profitability ratios
for Magforce AG.

Provide ROE
for Magforce AG.

Provide ROA
for Magforce AG.

Provide ROIC
for Magforce AG.

Provide ROCE
for Magforce AG.

Provide Gross Margin
for Magforce AG.

Provide Operating Margin
for Magforce AG.

Provide Net Margin
for Magforce AG.

Provide FCF Margin
for Magforce AG.

Show all solvency ratios
for Magforce AG.

Provide D/E Ratio
for Magforce AG.

Provide D/A Ratio
for Magforce AG.

Provide Interest Coverage Ratio
for Magforce AG.

Provide Altman Z-Score Ratio
for Magforce AG.

Provide Quick Ratio
for Magforce AG.

Provide Current Ratio
for Magforce AG.

Provide Cash Ratio
for Magforce AG.

What is the historical Revenue growth
over the last 5 years for Magforce AG?

What is the historical Net Income growth
over the last 5 years for Magforce AG?

What is the current Free Cash Flow
of Magforce AG?

Discuss the annual earnings per share (EPS)
trend over the past five years for Magforce AG.

Financials

Balance Sheet Decomposition
Magforce AG

Current Assets 1.3m
Cash & Short-Term Investments 114.7k
Receivables 736.1k
Other Current Assets 460.1k
Non-Current Assets 61.5m
Long-Term Investments 56.6m
PP&E 3m
Intangibles 1.6m
Other Non-Current Assets 412.6k
Current Liabilities 33.8m
Accounts Payable 648k
Accrued Liabilities 71.7k
Short-Term Debt 8.9m
Other Current Liabilities 24.2m
Non-Current Liabilities 2.2m
Other Non-Current Liabilities 2.2m
Efficiency

Earnings Waterfall
Magforce AG

Revenue
352k EUR
Cost of Revenue
-668.6k EUR
Gross Profit
-316.6k EUR
Operating Expenses
-6m EUR
Operating Income
-6.3m EUR
Other Expenses
-4.3m EUR
Net Income
-10.6m EUR

Free Cash Flow Analysis
Magforce AG

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

MF6 Profitability Score
Profitability Due Diligence

Magforce AG's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Negative Free Cash Flow
Negative Operating Income
Negative Net Income
Positive 3-Year Average ROIC
43/100
Profitability
Score

Magforce AG's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

MF6 Solvency Score
Solvency Due Diligence

Magforce AG's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Positive Net Debt
Short-Term Solvency
33/100
Solvency
Score

Magforce AG's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MF6 Price Targets Summary
Magforce AG

There are no price targets for MF6.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

MF6 Price
Magforce AG

1M 1M
-
6M 6M
-
1Y 1Y
-
3Y 3Y
-98%
5Y 5Y
-98%
10Y 10Y
-99%
Annual Price Range
0.081
52w Low
N/A
52w High
N/A
Price Metrics
Average Annual Return 5.37%
Standard Deviation of Annual Returns 24.42%
Max Drawdown -99%
Shares Statistics
Market Capitalization 2.4m EUR
Shares Outstanding 29 462 500
Percentage of Shares Shorted
N/A

MF6 Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Magforce AG

Country

Germany

Industry

Health Care

Market Cap

2.4m EUR

Dividend Yield

0%

Description

MagForce AG engages in the development and distribution of a nanotechnology based cancer therapy. The company is headquartered in Berlin, Berlin and currently employs 67 full-time employees. The company went IPO on 2007-09-21. Its non-invasive technology uses magnetic nanoparticles to combat tumors, without harmful effect on the healthy tissues. The firm's range of treatment products includes NanoTherm Therapie for treating tumors locally; NanoTherm, a fluid containing ferrous oxide molecules that penetrate deeply into the tumor tissues and reacting to the presence of a magnetic field; NanoActivator, which are iron oxide nanoparticles for tumors in all areas of the body, and NanoPlan, a software platform that facilitates therapy planning and adjusts proper temperatures for the treatment and and the necessary magnetic field strength. As of December 31, 2011, Nanostart AG held a 49.6%-stake in the Company.

Contact

BERLIN
Berlin
Max-Planck-Strasse 3
+49303083800.0
https://www.magforce.com/

IPO

2007-09-21

Employees

67

Officers

Chairman of the Management Board & CEO
Dr. Benjamin J. Lipps
CFO & Member of Management Board
Mr. Christian Von Volkmann M.B.A., MBA
Exec. VP, Chief Scientific Officer & MD of Europe
Dr. Andreas Jordan
VP of Communications & Investor Relations
Ms. Barbara Von Frankenberg
VP of Marketing & Sales and European Commercial Director
Ms. Solveig Salomon
Medical Consultant
Dr. Hans Joachim Hutt M.D., Ph.D.

See Also

Discover More